AK

Atulkumar Kantilal Shah

Active Director Director DIN 00112637
DIN 00112637 First appointment Jan 1993 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 1993
Shareholding value •••• Premium profile

About Atulkumar Kantilal Shah

Data last updated:

Atulkumar Kantilal Shah is a Director at Mayank And Lili Pharma Private Limited (since 1993). The company operates in Chemicals. Mayank And Lili Pharma Private Limited reported revenue of ₹38.5 Lakh (FY 2020).

DIN 00112637
Primary Designation Director
Industry Chemicals
First Appointment 05 Jan 1993
Oldest Company Age 33 yrs
Largest company Mayank And Lili Pharma Private Limited · ₹38.5 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 19931993₹38.5 Lakh (FY 2020)Active

Board colleagues of Atulkumar Kantilal Shah

Directorship timeline

Open interactive timeline →
Mayank And Lili Pharma Private Limited
Premium access

Shareholding and investment profile for Atulkumar Kantilal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atulkumar Kantilal Shah

Atulkumar Kantilal Shah currently holds 1 directorship: Mayank And Lili Pharma Private Limited (Director, since 05 Jan 1993, revenue ₹38.5 Lakh (FY 2020)).

Atulkumar Kantilal Shah was first appointed on 05 Jan 1993 as Director at Mayank And Lili Pharma Private Limited.

The current boards of Atulkumar Kantilal Shah's companies include Mayankkumar Kantilal Shah (Mayank And Lili Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available